Amidst a public outcry over the safety and efficacy of vaccines, Chinese officials and law enforcement agencies are rapidly pushing ahead with their investigations. Their initial findings point to systematic data production and manipulated surveillance tapes at one of the largest vaccine manufacturers in China. 19659002] The local police are now asking the prosecutor's office to authorize the arrest of 18 people for the production and sale of defective drugs. These people, the chairman of Changchun Changsheng Life Sciences, Gao Junfang, were found to be linked to alleged illicit drugs during Changsheng's rabies vaccination, Changchun City Police said in a Sunday statement.
The police movement came right after the unveiling of similar findings
Investigators found that the company breached the approved manufacturing process to cut costs and improve the success rate of rabies vaccine production Xinghua News Agency.
Changsheng mixed various batches of crude active antigenic substances in their final products, the team reported. In some cases, the company used expired materials and counterfeited the production date. It has also been found that the obligatory mouse challenge test used to determine the rabies vaccine potency in the final products prior to the raw material phase has been postponed.
To cover up this, "the company systematically produced production and test records" How mice buy bills, the inspection team found. After a surprise inspection by the drug commissioner revealed wrongdoing, the company manipulated surveillance tapes and computer data. The local police have retrieved 60 computer hard drives that the company wanted to destroy.
RELATED: Opportunity for global vaccine manufacturers? China's recent vaccine scandal sparked anger and anxiety
After the Chengsheng state Chinese drug agency uncovered data-processing concerns and withdrew its rabies vaccine GMP license two weeks ago, the scandal has turned into a riot over vaccine safety and efficacy. Although there were no reports of serious adverse events related to rabies vaccines, public confidence in domestic vaccines has been shaken.
Shenzhen-listed Changsheng is China's second largest rabies vaccine manufacturer and has delivered 3.69 million rabies vaccines. According to the annual report, the country is the second largest provider of chickenpox vaccines in 2017. In November 2017, 252,600 doses of acellular diphtheria / pertussis / tetanus (DTaP) vaccine intended for children were also found to be ineffective. Gao's family ranked No. 1 on Forbes' China Rich List 2016 with $ 1 billion in assets.
The recent actions of the Chinese government, conducted under the direct orders of President Xi Jinping and Prime Minister Li Keqiang, are a series of synchronized actions to curb the public's anger and restore confidence in its food and drug industry. The drug agency has launched a comprehensive campaign to investigate all vaccine manufacturers for misconduct. The China Securities Regulatory Commission revised its delisting rule on Friday and added measures that threaten public health as a new condition for forced delisting.